CHD6 is a novel oxidative DNA damage response factor
Dr Aaron Goodarzi, Arnie Charbonneau Cancer Institute
Date & Time:
Monday, 23 October 2017, 11:00
Old Road Campus Research Building, Meeting rooms 71a, b and c, Headington OX3 7DQ
Department of Oncology
We aim to enhance clinical and basic cancer research in Oxford with the ultimate goal of increasing cancer cure rates.
In Oxford, we have a great wealth of broad-ranging expertise and a powerful network of cancer researchers.
Study With Us
Our graduate training programmes for both scientists and clinicians are internationally recognised.